Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
4,440,602
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
63,007
-
Shares change
-
-158,063
-
Total reported value, excl. options
-
$141,366
-
Value change
-
-$294,712
-
Number of buys
-
6
-
Number of sells
-
4
-
Price
-
$2.25
Institutional Holders of Virax Biolabs Group Ltd - Ordinary Shares (VRAX) as of Q4 2024
As of 31 Dec 2024 Virax Biolabs Group Ltd - Ordinary Shares (VRAX) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,007 shares of stock of the company.
Largest 7 holders included UBS Group AG, XTX Topco Ltd, Royal Bank of Canada, R Squared Ltd, MORGAN STANLEY, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and Tower Research Capital LLC (TRC).
This table shows 7 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.